“We are very excited about the HealthWatch trial at Reliance Hospital, Mumbai.
The first patient of the trial was tested today, using HealthWatch’s Master Caution. According to the patient, the garment is pleasant on the skin. Compared to other ECG devices, signals seem to be accurate and stable when conducted remotely. We are looking forward to such successful events during the remaining of the trial”.
“We are very excited about the HealthWatch trial at Reliance Hospital, Mumbai.Dr. Manoj R. Mashru, MD, DM, FACC, Cardiologist, Reliance Foundation Hospital, Mumbai, India.
Dr. Mashru, Dr. Hila Dagan (VP Clinical Affairs, HealthWatch) and the first patient.
Dr. Mashru, Dr. Hila Dagan (VP Clinical Affairs, HealthWatch), Harit Agrawal and Rishit Agrawal, Managing Directors at Nuveos and the first patient.
